(Q31808981)

4 July 2017

title

Buprenorphine: "field trials" of a new drug (English)

1 reference

4 July 2017

M Agar

1

1 reference

4 July 2017

P Bourgois

series ordinal

2

1 reference

4 July 2017

J French

series ordinal

3

1 reference

4 July 2017

O Murdoch

series ordinal

4

1 reference

4 July 2017

publication date

1 January 2001

1 reference

Qualitative Health Research

4 July 2017

published in

1 reference

4 July 2017

volume

11

1 reference

4 July 2017

issue

1

1 reference

4 July 2017

page(s)

69-84

1 reference

Disciplining addictions: the bio-politics of methadone and heroin in the United States

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Problem drug use in a central London general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Comparison of buprenorphine and methadone maintenance in opiate addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Drug misusers in Lothian: changes in injecting habits 1988-90

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Building a city wide service for exchanging needles and syringes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Sublingual versus subcutaneous buprenorphine in opiate abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

A controlled trial of buprenorphine treatment for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Buprenorphine and naloxone interactions in methadone maintenance patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

A pilot study of primary-care-based buprenorphine maintenance for heroin dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

A comparison of four buprenorphine dosing regimens in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Subjective and physiologic effects of intravenous buprenorphine in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Effects of acute buprenorphine on responses to intranasal cocaine: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Prognostic factors in Buprenorphine- versus methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Effect of scheduling of buprenorphine (Temgesic) on drug abuse patterns in Glasgow

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Abuse of buprenorphine (Temgesic) by snorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104973201129118948

10.1177/104973201129118948

21 January 2018

Identifiers

DOI

1 reference

4 July 2017

1 reference